Other technical consultancy
NORSK BIOKRAFT AS
Revenue 2024
NOK 7.5m
Operating profit
NOK −1.8m
Equity
NOK −1.9m
Incorporated
2012
Share capital
NOK 1.9m
Key figures · 2024
Current ratio
0.59
Equity ratio
-46.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -24.1% | |
| Net margin (%%) | -35.0% | |
| Return on assets (%%) | -44.9% | |
| Likviditet | ||
| Current ratio | 0.59 | |
| Working capital | −2.4m | |
| Soliditet | ||
| Equity ratio (%%) | -46.2% | |
| Debt-to-equity ratio | -3.16 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.